We are live on
!
Find out more
CCI
Columbus Circle Investors Portfolio holdings
AUM
$2.28B
1-Year Est. Return
135.57%
This Fund
S&P 500
This Quarter
Est. Return
+11.3%
1 Year Est. Return
+135.57%
3 Year Est. Return
+366.4%
5 Year Est. Return
+795.38%
10 Year Est. Return
–
AUM
$14.1B
AUM Growth
+$208M
(+1.5%)
Cap. Flow
-$745M
Cap. Flow
% of AUM
-5.27%
Top 10 Holdings %
Top 10 Hldgs %
23.71%
Holding
357
New
97
Increased
86
Reduced
104
Closed
70
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bath & Body Works
BBWI
|
+$141M |
| 2 |
Capital One
COF
|
+$133M |
| 3 |
Target
TGT
|
+$108M |
| 4 |
Intuitive Surgical
ISRG
|
+$101M |
| 5 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$86.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$252M |
| 2 |
American Express
AXP
|
+$177M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
Masco
MAS
|
+$143M |
| 5 |
Booking.com
BKNG
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.9% |
| 2 | Technology | 19.27% |
| 3 | Consumer Discretionary | 17.25% |
| 4 | Financials | 10.81% |
| 5 | Industrials | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KIN
276
DELISTED
Kindred Biosciences, Inc.
KIN
| $544K | ﹤0.01% |
72,990
+44,961
| +160% | +$381K |
|
|
TUBE
277
DELISTED
TubeMogul, Inc.
TUBE
| $513K | ﹤0.01% |
+22,740
| New | +$367K |
|
|
BLOX
278
DELISTED
Infoblox Inc
BLOX
| $460K | ﹤0.01% |
+22,780
| New | +$381K |
|
279
JD.com
JD
$44.5B
| $409K | ﹤0.01% |
+17,660
| New | +$435K |
|
|
NMBL
280
DELISTED
Nimble Storage, Inc.
NMBL
| $380K | ﹤0.01% |
13,810
-6,952
| -33% | -$185K |
|
|
NVRO
281
DELISTED
NEVRO CORP.
NVRO
| $358K | ﹤0.01% |
+9,258
| New | +$292K |
|
|
KITE
282
DELISTED
Kite Pharma, Inc.
KITE
| $352K | ﹤0.01% |
+6,110
| New | +$257K |
|
|
ADVM
283
DELISTED
Adverum Biotechnologies
ADVM
| $350K | ﹤0.01% |
+649
| New | +$250K |
|
284
Tempest Therapeutics
TPST
$14.6M
| $321K | ﹤0.01% |
+2
| New | +$146K |
|
285
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| $260K | ﹤0.01% |
+5,582
| New | +$252K |
|
|
ESPR
286
DELISTED
Esperion Therapeutics
ESPR
| $248K | ﹤0.01% |
+6,133
| New | +$188K |
|
287
Canadian Solar
CSIQ
$1.08B
| $203K | ﹤0.01% |
8,399
-7,044
| -46% | -$192K |
|
288
Agilent Technologies
A
$41.2B
| – | – |
-145,461
| Closed | -$5.93M |
|
289
Aecom
ACM
$9.75B
| – | – |
-1,189,360
| Closed | -$40.1M |
|
290
Ambarella
AMBA
$3.81B
| – | – |
-173,980
| Closed | -$7.6M |
|
|
AMRN
291
Amarin Corp
AMRN
$303M
| – | – |
-17,893
| Closed | -$390K |
|
292
Abercrombie & Fitch
ANF
$5B
| – | – |
-482,181
| Closed | -$17.5M |
|
293
Accuray
ARAY
$34M
| – | – |
-81,848
| Closed | -$594K |
|
|
294
American Express
AXP
$230B
| – | – |
-2,020,954
| Closed | -$177M |
|
295
Belden
BDC
$5.19B
| – | – |
-354,949
| Closed | -$22.7M |
|
|
296
Booking.com
BKNG
$161B
| – | – |
-2,580,800
| Closed | -$120M |
|
297
Ciena
CIEN
$58.4B
| – | – |
-1,728,177
| Closed | -$28.9M |
|
298
Comcast
CMCSA
$90B
| – | – |
-26,344
| Closed | -$708K |
|
299
Centene
CNC
$32.5B
| – | – |
-693,132
| Closed | -$14.3M |
|
300
Eagle Materials
EXP
$6.57B
| – | – |
-839,009
| Closed | -$85.4M |
|
Similar funds
SWM
LCM
HCMNY
BII
HCM
DBC
DK
AVAX
Columbus Circle Investors's Q4 2014 Portfolio in Review
As of Q4 2014, Columbus Circle Investors held 357 positions worth $14.1B, up 1.5% from $13.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Columbus Circle Investors withdrew a net $745M in Q4 2014, closing 70 positions and reducing 104 holdings. Its most notable exit was Halliburton, an estimated $252M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Columbus Circle Investors opened a new position in Bath & Body Works worth $160M.
- Columbus Circle Investors's largest Q4 2014 buy was Bath & Body Works: 2,284,351 shares worth $160M.
- Columbus Circle Investors added most to Intuitive Surgical in Q4 2014, an estimated $101M increase.
- Columbus Circle Investors's biggest Q4 2014 reduction was Biogen, cutting an estimated $177M.
- Columbus Circle Investors fully exited Halliburton in Q4 2014, selling an estimated $252M.
- Columbus Circle Investors's ten largest holdings make up 24% of its $14.1B portfolio in Q4 2014.
- Columbus Circle Investors opened 97 new positions and closed 70 in Q4 2014.
- Columbus Circle Investors's portfolio value rose 1.5% quarter-over-quarter to $14.1B.
Based on Columbus Circle Investors's 13F filing for Q4 2014, filed 5 Feb 2015.